Nr 508 pharm week 3 exam - Study guides, Class notes & Summaries

NR 508 Final Exam study guide Cardiovascular management: 1. Know Initial treatment choices for HTN AceI- sartans Arbs- ipine, verapamil & diltazem Thiazide- iaside, chlorthalidone, imdapamide, metolazone calcium channel blocker 2. Know first line treatment options for HTN for African Americans without renal impairment. Calcium channel blockers Thiazide 3. First line option for HTN for anyone with chronic kidney disease Ace inhibitors ARB’s Diuretics: 4. Types, Uses, Side eff...

NR 508 NR508 ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS EXAM 3 A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medicat...

NR 508 NR508 ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS EXAM 3 A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medicat...

NR 508 NR508 ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS EXAM 3 NR 508 NR508 ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS EXAM 3 A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin ...